Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Oxford Asymmetry


Oxford Asymmetry is to be acquired by Evotec of Germany for £285m, in order to create one of the world's leading suppliers of drug discovery services.
01-Aug-2000


Oxford Asymmetry, the biotechnology company, has raised £18m in a share placing that will enable it to invest in new staff, premises and technology.
11-Mar-1998


Oxford Asymmetry, the speciality chemicals company, is planning a flotation in order to raise £20m to invest in laboratories, technology and new staff.
20-Jan-1998